Aalberts Industries NV (0NX1)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 41.28 |
|---|---|
| 52-week range | 24.77 – 45.24 |
| Return, 1 month / 3 months | +1.3% / +3.1% |
| Return, 1 year / 3 years | +57.2% / +52.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 32.0% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 3.06M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aalberts Industries is a Dutch industrial group based in Utrecht that supplies flow control systems and industrial components. Its flow control business makes valves, fittings, piping and related products for water, gas, heating and cooling applications used in buildings and infrastructure. The company also provides surface treatment and heat treatment services and engineered components for equipment makers and industrial customers. It serves installers, contractors, utilities and manufacturers across Europe and other regions.
On this site Aalberts Industries NV appears as a stock on the London Exchange (UK), code 0NX1, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aalberts Industries NV (0NX1) trades on the London Exchange in UK. It last closed at EUR 41.28 on 19 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 388 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 57.2% and over the last three months it rose 3.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.2% | ||
| From 52-week high | -7.6% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.1% | ||
| 6-month return | 30.6% | ||
| 12-month return, skipping the last month | 55.2% | ||
| Risk (lower is better) | 68 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 32.0% | ||
| Worst drawdown (1 year) | -17.7% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | +1.3% |
| 3 months | +3.1% |
| 6 months | +30.6% |
| 1 year | +57.2% |
| 3 years | +52.8% |
| 5 years | −0.1% |
Signals
| 50-day / 200-day average | 42.60 / 36.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Apr 2026 | EUR 1.1500 |
| 14 Apr 2025 | EUR 1.1300 |
| 24 May 2024 | EUR 1.1300 |
| 30 May 2023 | EUR 1.1100 |
| 23 May 2022 | EUR 1.0100 |
| 31 May 2021 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.